Skip to menu Skip to content Skip to footer

2005

Journal Article

Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms

Pettigrew, Christopher, Wayte, Nicola, Lovelock, Paul K., Tavtigian, Sean V, Chenevix-Trench, Georgia, Spurdle, Amanda B. and Brown, Melissa A. (2005). Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms. Breast Cancer Research, 7 (6) R929, R929-R939. doi: 10.1186/bcr1324

Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms

2005

Journal Article

Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk

Kuschel, Bettina, Chenevix- Trench, Georgia, Spurdle, Amanda B., Chen, Xiaoqing, Hopper, John L., Giles, Graham G., McCredie, Margret, Chang-Claude, Jenny, Gregory, Catherine S., Day, Nick E., Easton, Douglas F., Ponder, Bruce A. J., Dunning, Alison M. and Pharoah, Paul D. P. (2005). Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention, 14 (7), 1828-1831. doi: 10.1158/1055-9965.EPI-04-0807

Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk

2005

Journal Article

Two ATM variants and breast cancer risk

Thompson, Deborah, Antoniou, Antonis C., Jenkins, Mark, Marsh, Anna, Chen, Xiaoqing, Wayne, Tierney, Tesoriero, Andrea, Milne, Roger, Spurdle, Amanda, Thorstenson, Yvonne, Southey, Melissa, Giles, Graham G., kConFab Investigators,, Khanna, Kum Kum, Sambrook, Joseph, Oefner, Peter, Goldgar, David, Hopper, John L., Easton, Doug and Chenevix-Trench, Georgia (2005). Two ATM variants and breast cancer risk. Human Mutation, 25 (6), 594-595. doi: 10.1002/humu.9344

Two ATM variants and breast cancer risk

2005

Journal Article

Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer

Webb, Penelope, Hopper, John L., Newman, Beth, Chen, Xiaoqing, Kelemen, Livia, Giles, Graham G., Southey, Melissa C., Chenevix-Trench, Georgia and Spurdle, Amanda B. (2005). Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiology Biomarkers and Prevention, 14 (2), 319-323. doi: 10.1158/1055-9965.EPI-04-0335

Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer

2005

Journal Article

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study

Chang, Jiun-Horng, Gertig, Dorota M., Chen, Xiaoqing, Dite, Gillian S., Jenkins, Mark A., Milne, Roger L., Southey, Melissa C., McCredie, Margaret R. E., Giles, Graham G., Chenevix-Trench, Georgia, Hopper, John L. and Spurdle, Amanda B. (2005). CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Research, 7 (4) R513, R513-R521. doi: 10.1186/bcr1040

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study

2005

Journal Article

Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families

Tesoriero, A. A., Wong, E. M., Jenkins, M. A., Hopper, J. L., KConFab, K. C. F., Brown, M. A., Chenevix-Trench, G., Spurdle, A. B. and Southey, M. C. (2005). Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Human Mutation, 26 (5), 495-495. doi: 10.1002/humu.9379

Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families

2005

Journal Article

Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals

Jekimovs, C. R., Chen, X., Arnold, J., Gatei, M., Richardson, D. J., kConFab Investigators, Spurdle, A. B., Khanna, K. K. and Chenevix-Trench, G. (2005). Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals. British Journal Of Cancer, 92 (4), 784-790. doi: 10.1038/sj.bjc.6602381

Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals

2005

Journal Article

RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women

Kelemen, Livia, Spurdle, Amanda B., Purdie, David M., Gertig, Dorota and Chenevix-Trench, Georgia (2005). RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women. Cancer Letters, 218 (2), 191-197. doi: 10.1016/j.canlet.2004.09.023

RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women

2003

Journal Article

BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk

Auranen, Annika, Spurdle, Amanda B., Chen, Xiaoqing, Lipscombe, Julian, Purdie, David M., Hopper, John L., Green, Adele, Healey, Catherine S., Redman, Karen, Dunning, Alison M., Pharoah, Paul D., Easton, Douglas F., Ponder, Bruce A.J., Chenevix-Trench, Georgia and Novik, Karen L. (2003). BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk. International Journal of Cancer, 103 (3), 427-430. doi: 10.1002/ijc.10814

BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk

2002

Journal Article

Prohibitin 3′ untranslated region polymorphism and breast cancer risk in Australian women

Spurdle, Amanda B., Hopper, John L., Chen, Xiaoqing, McCredie, Margaret R. E., Giles, Graham G., Newman, Beth and Chenevix-Trench, Georgia (2002). Prohibitin 3′ untranslated region polymorphism and breast cancer risk in Australian women. Lancet, 360 (9337), 925-926. doi: 10.1016/S0140-6736(02)11043-9

Prohibitin 3′ untranslated region polymorphism and breast cancer risk in Australian women

2002

Journal Article

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years

Spurdle, Amanda B., Hopper, John L., Chen, Xiaoqing, Dite, Gillian S., Cui, Jisheng, McCredie, Margaret R. E., Giles, Graham G., Ellis-Steinborner, Sarah, Venter, Deon J., Newman, Beth, Southey, Melissa C. and Chenevix-Trench, Georgia (2002). The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiology Biomarkers & Prevention, 11 (4), 413-416.

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years

2002

Journal Article

Dominant negative ATM mutations in breast cancer families

Chenevix-Trench, Georgia, Spurdle, Amanda B., Gatei, Magtouf, Kelly, Helena, Marsh, Anna, Chen, Xiaoqing, Donn, Karen, Cummings, Margaret C., Nyholt, Dale, Jenkins, Mark A., Scott, Clare, Pupo, Gulietta M., Dork, Thilo, Bendix, Regina, Kirk, Judy, Tucker, Katherine, McCredie, Margaret R. E., Hopper, John L., Sambrook, Joseph, Mann, Graham J. and Khanna, Kum Kum (2002). Dominant negative ATM mutations in breast cancer families. Journal of the National Cancer Institute, 94 (3), 205-215. doi: 10.1093/jnci/94.3.205

Dominant negative ATM mutations in breast cancer families

2002

Journal Article

No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer

Spurdle, Amanda B., Hopper, John L., Chen, Xiaoqing, McCredie, Margaret R. E., Giles, Graham G., Newmann, Beth, Chenevix-Trench, Georgia and Khanna, KumKum (2002). No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Research, 4 (6) R15, R15/1-R15/6. doi: 10.1186/bcr534

No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer

2002

Journal Article

The progesterone receptor exon 4 Va1660Leu G/T polymorphism and risk of breast cancer in Australian women

Spurdle, Amanda B., Hopper, John L., Chen, Xiaoqing, McCredie, Margaret R. E., Giles, Graham G., Venter, Deon J., Southey, Melissa C. and Chenevix-Trench, Georgia (2002). The progesterone receptor exon 4 Va1660Leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiology Biomarkers & Prevention, 11 (5), 439-443.

The progesterone receptor exon 4 Va1660Leu G/T polymorphism and risk of breast cancer in Australian women

2001

Journal Article

The steroid 5α-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women

Spurdle, Amanda B., Hopper, John L., Chen, Xiaoqing, Dite, Gillian S., McCredie, Margaret R. E., Giles, Graham G., Venter, Deon J., Southey, Melissa C., Purdie, David M. and Chenevix-Trench, Georgia (2001). The steroid 5α-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. Cancer Epidemiology, Biomarkers and Prevention, 10 (12), 1287-1293.

The steroid 5α-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women

2001

Journal Article

No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer

Spurdle, Amanda B., Webb, Penelope M., Purdie, David M., Chen, Xiaoqing, Green, Adele and Chenevix-Trench, Georgia (2001). No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer. Carcinogenesis, 22 (5), 717-721. doi: 10.1093/carcin/22.5.717

No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer

2001

Journal Article

The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer

Spurdle, Amanda B., Purdie, David M., Webb, Penelope M., Chen, Xiaoqing, Green, Adele and Chenevix-Trench, Georgia (2001). The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer. Molecular Carcinogenesis, 30 (1), 71-78. doi: 10.1002/1098-2744(200101)30:13.0.CO;2-9

The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer

2001

Journal Article

The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia

Marsh, Anna, Spurdle, Amanda B., Turner, Bruce C., Fereday, Sian, Thorne, Heather, Pupo, Gulietta M., Mann, Graham J., Hopper, John L., Sambrook, Joseph F., Chenevix-Trench, Georgia, Australian Breast Canc Family Stud and K Cunningham Fdn Consortium Res Fa (2001). The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia. Breast Cancer Research, 3 (5) 346, 346-349. doi: 10.1186/bcr319

The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia

2001

Journal Article

Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype

Spurdle, Amanda B., Webb, Penelope M., Purdie, David M., Chen, Xiaoqing, Green, Adele and Chenevix-Trench, Georgia (2001). Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis, 22 (1), 67-72. doi: 10.1093/carcin/22.1.67

Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype

2000

Journal Article

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years

Spurdle, Amanda B., Hopper, John L., Dite, Gillian S, Chen, Xiaoqing, Cui, Jisheng, McCredie, Margaret R. E., Giles, Graham G., Southey, Melissa C., Venter, Deon J., Easton, Douglas F. and Chenevix-Trench, Georgia (2000). CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. Journal of the National Cancer Institute, 92 (20), 1674-1681. doi: 10.1093/jnci/92.20.1674

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years